Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2006-09-05
2006-09-05
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C428S402200, C514S824000
Reexamination Certificate
active
07101570
ABSTRACT:
The present invention provides compositions and methods for treating atherosclerosis. The compositions comprise unilamellar liposomes having an average diameter of 100-150 nanometers. Methods for treating atherosclerosis employing the compositions of the present invention are also provided.
REFERENCES:
patent: 4186183 (1980-01-01), Steck et al.
patent: 4187180 (1980-02-01), Joh
patent: 4217344 (1980-08-01), Vanlerberghe et al.
patent: 4247393 (1981-01-01), Wallace
patent: 4261975 (1981-04-01), Fullerton et al.
patent: 4485054 (1984-11-01), Mezei et al.
patent: 4532089 (1985-07-01), MacDonald
patent: 4663167 (1987-05-01), Lopez-Berestein et al.
patent: 4774085 (1988-09-01), Fildler
patent: 4804539 (1989-02-01), Guo
patent: 4812314 (1989-03-01), Barenholz
patent: 4895719 (1990-01-01), Radhakrishnan et al.
patent: 4923439 (1990-05-01), Seidel
patent: 4927637 (1990-05-01), Morano et al.
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 4978654 (1990-12-01), Lopez-Berestein et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5015483 (1991-05-01), Haynes et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5180366 (1993-01-01), Woods
patent: 5204112 (1993-04-01), Hope et al.
patent: 5219888 (1993-06-01), Katocs, Jr. et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5231090 (1993-07-01), Hsia et al.
patent: 5250060 (1993-10-01), Carbo et al.
patent: 5252263 (1993-10-01), Hope et al.
patent: 5258499 (1993-11-01), Konigsberg
patent: 5376452 (1994-12-01), Hope et al.
patent: 5405832 (1995-04-01), Potempa
patent: 5427926 (1995-06-01), Buonassisi et al.
patent: 5489611 (1996-02-01), Lee et al.
patent: 5527538 (1996-06-01), Baldeschweela
patent: 5556637 (1996-09-01), Hager et al.
patent: 5595756 (1997-01-01), Bally et al.
patent: 5599306 (1997-02-01), Klein et al.
patent: 5622715 (1997-04-01), Barenholz et al.
patent: 5637315 (1997-06-01), Zern et al.
patent: 5674488 (1997-10-01), Reich
patent: 5705385 (1998-01-01), Bally et al.
patent: 5741514 (1998-04-01), Barenholz et al.
patent: 5741517 (1998-04-01), Hager et al.
patent: 5753613 (1998-05-01), Ansell et al.
patent: 6139871 (2000-10-01), Hope
patent: 6241967 (2001-06-01), Sachse et al.
patent: 6312719 (2001-11-01), Hope et al.
patent: 40 18 767 (1991-12-01), None
patent: 0 234 919 (1987-09-01), None
patent: 0470437 (1991-07-01), None
patent: 0 461 559 (1991-12-01), None
patent: 0 470 437 (1992-02-01), None
patent: WO 86/01404 (1986-03-01), None
patent: WO 88/09345 (1988-12-01), None
patent: WO 91/17424 (1991-11-01), None
patent: WO 95/23592 (1995-09-01), None
The Molecular Basics of Cancer, Ed. by P.B. Fanner OJ. M. Walker, pp. 262-283, 1985.
Liu & Huang in BBA 1022, p. 348-354, 1990.
William in Perspectives in Biol. Med 27 p. 417-431, 1984.
Williams in BBA 875, 183-194, 1986.
Thomas et al. Effect of surface curvature on the rate of cholesterol transfer between lipids. Biochem J., 254:155-60 (1988).
Davidson WS, et al. Effects of acceptor particle size on the efflux of cellular free cholesterol. J Biol Chem. Jul. 21, 1995;270(29):17106-113.
Guyard-Dangremont et al. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. Comp Biochem Physiol B Biochem Mol Biol. Jul. 1998;120(3):517-25.
Klimov et al. “Essential” phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. Cardiovasc Drugs Ther. Dec. 1995;9(6):779-84.
Rodrigueza et al. Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol. Arterioscler Thromb Vasc Biol. Feb. 1997;17(2):383-93.
Spady et al. Reverse cholesterol transport and atherosclerosis regression. Circulation. Aug. 10, 1999;100(6):576-8. No abstract available.
Adams et al. Effect of oral polyunsaturated lecithin on the development of atheroma and fatty liver in the cholesterol-fed rabbit.J. Pathol. Bacteriol.1969, 97:35-41.
Adams et al. Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polyunsaturated lecithins. J. Pathol. Bacteriol. 1967, 94:777-87.
Allen et al. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta. Jul. 26, 1995;1237(2):99-108.
Allen, J. of Liposome Res. 1992, 2(3):289-305.
Altman et al. Phospholipids in experimental atherosclerosis. Arzneimittelforschung. Jan. 1974;24(1):11-6.
Aviram et al. Intralipid infusion abolishes ability of human serum to cholesterol-load cultured macrophages. Arteriosclerosis. Jan.-Feb. 1989;9(1):67-75.
Aviram et al. Macrophage cholesterol removal by triglyceride-phospholipid emulsions. Biochem Biophys Res Commun. Sep. 15, 1988;155(2):709-13.
Bally et al. Novel procedures for generating and loading liposomal systems. InLiposomes as drug carriers: Recent Trends and Progress(Gregoriadis G., ed.) Pp841-853, John Wiley & Sons Ltd., Chichester, England, 1988.
Bangham et al. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. Aug. 1965;13(1):238-52.
Barclay et al. Partitioning and antioxidant action of the water-soluble antioxidant, Trolox, between the aqueous and lipid phases of phosphatidylcholine membranes: 14C tracer and product studies. Biochim Biophys Acta. Jul. 6, 1995;1237(1):77-85.
Bialecki et al. Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells. J Clin Invest Dec. 1991;88(6):1894-900.
Bisgaier et al. Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J Biol Chem. Jan. 15, 1989;264(2):862-6.
Bisgaier et al. Effect of lecithin: cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. J Lipid Res. Jun. 1987;28(6):693-703.
Blaton et al. The human plasma lipids and lipoproteins under influence of EPL-therapy. InPhosphatidylcholine(Peeters, H., ed.) pp 125-132, Springer-Verlag: Berlin, 1976.
Bligh et al. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959; 37:911-917.
Bloomfield VA. Quasi-elastic light scattering applications in biochemistry and biology. Annu Rev Biophys Bioeng. 1981;10:421-50. Review.
Bottger G, Strik W. [Fat embolism] Munch Med Wochenschr. Jan. 9, 1970;112(2):51-8. German.
Byers et al. Effect of infusions of phosphatides upon the atherrosclerosis aorta in situ and as an ocular aortic implant. J. Lipid Res. 1960; 1:343-349.
Campanacci et al. Response of plasma lipid fractions to the administration of exogenous phospholipids. Arzneimittelforschung. Aug. 1975;25; (8):1306-8.
Chakrabarti et al. Influence of charge, charge distribution, and hydrophobicity on the transport short model peptides into liposomes in response to transmembrane pH gradients. Biochemistry. Jul. 19, 1994;33(28):8479-85.
Chisolm et al. Antioxidants and Atherosclerosis: A Current Assessment. Clin. Cardiol. 1991; 14:25-30.
Ciammaichella et al. Polyunsaturated phosphatidyl choline (EPL) in the treatment of cerebral arteriosclerosis and arteriosclerosis of the lower extremities. Clin Ter. Jul. 15, 1975; 74(1):55-62. Italian.
Constantinides et al. Production of advanced cholesterol atherosclerosis in the rabbit. Arch. Pathol. 1961; 70:81-102.
Daida et al. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group. Am J Cardiol. Jun. 1, 1994;73(15):1037-40.
Davidson et al. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem. Mar. 17, 1995;270(11):5882-90.
Davidson et al. Association and release of prostaglandin E1 from liposomes. Biochim Biophys Acta. Jul. 5, 1997;1327(1):97-106.
De Caterina R & Lenzi S. Prevention and therapy of vascular damage and endothelial dysfunction with hypoch
Hope Michael J.
Rodrigueza Wendi
Jones Day
Kishore Gollamudi S.
The University of British Columbia
LandOfFree
Liposome compositions and methods for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposome compositions and methods for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome compositions and methods for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3547053